Nisa Investment Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.9K | Buy |
470
+290
| +161% | +$9.16K | ﹤0.01% | 2079 |
|
|
2025
Q1 | $5.97K | Buy |
180
+42
| +30% | +$1.39K | ﹤0.01% | 2209 |
|
|
2024
Q4 | $4.75K | Sell |
138
-5,422
| -98% | -$187K | ﹤0.01% | 2290 |
|
|
2024
Q3 | $222K | Buy |
5,560
+5,498
| +8,868% | +$220K | ﹤0.01% | 1254 |
|
|
2024
Q2 | $1.87K | Buy |
62
+11
| +22% | +$332 | ﹤0.01% | 2382 |
|
|
2024
Q1 | $1.71K | Buy |
51
+26
| +104% | +$873 | ﹤0.01% | 2264 |
|
|
2023
Q4 | $808 | Sell |
25
-567
| -96% | -$18.3K | ﹤0.01% | 2302 |
|
|
2023
Q3 | $19.4K | Buy |
592
+22
| +4% | +$721 | ﹤0.01% | 2030 |
|
|
2023
Q2 | $20.1K | Buy |
570
+545
| +2,180% | +$19.2K | ﹤0.01% | 2107 |
|
|
2023
Q1 | $1K | Buy |
25
+6
| +32% | +$240 | ﹤0.01% | 2394 |
|
|
2022
Q4 | $1K | Hold |
19
| – | – | ﹤0.01% | 2440 |
|
|
2022
Q3 | $1K | Sell |
19
-158
| -89% | -$8.32K | ﹤0.01% | 2438 |
|
|
2022
Q2 | $9K | Hold |
177
| – | – | ﹤0.01% | 2203 |
|
|
2022
Q1 | $9K | Hold |
177
| – | – | ﹤0.01% | 2231 |
|
|
2021
Q4 | $6K | Sell |
177
-243
| -58% | -$8.24K | ﹤0.01% | 2076 |
|
|
2021
Q3 | $16 | Sell |
420
-3,409
| -89% | -$130 | ﹤0.01% | 2136 |
|
|
2021
Q2 | $108 | Hold |
3,829
| – | – | ﹤0.01% | 1650 |
|
|
2021
Q1 | $127 | Hold |
3,829
| – | – | ﹤0.01% | 1652 |
|
|
2020
Q4 | $138K | Buy |
+3,829
| New | +$138K | ﹤0.01% | 1609 |
|